Skip to profile

Andrew A.

Empowering Technological Transformation in Healthcare and Beyond

With over two decades of experience at the nexus of technology and healthcare, Andrew S. Atwell excels in driving innovation, strategic investment, and the scaling of digital health platforms. His expertise encompasses SaaS, AI-powered healthcare solutions, remote patient monitoring, and navigating the complexities of regulated medical technologies. At Omron Healthcare and Samsung NEXT, Andrew demonstrated unparalleled leadership. Equipped with an Executive MBA, he targets roles that demand strategic execution and innovation. His core proficiencies include spearheading new ventures, corporate development, and harnessing strategic partnerships to foster growth and technological advancement.
Hire Andrew
Andrew A.

Experience

Jan 2023 — Dec 2024
Ocu Health Care, Inc

Ocu Health Care, Inc

Chief Business Officer & Co-Founder

Ocu Health Care, Inc provides patient-centered solutions to improve health outcomes by reducing hospitalization costs through immersive educational experiences and A.I. technology.

  • Spearheaded the development and launch of the Ocu Health Care platform, creating a virtual reality solution that integrates with AI to reduce hospital readmission rates.
  • Led the company to secure first place at the PitchForce Select event, gaining recognition from top-tier investors and industry experts.
  • Facilitated partnerships with major medical centers, enhancing the platform's integration in hospital management and patient education.
Jan 2021 — Dec 2022
AdhereTech

AdhereTech

Vice President of Partnerships and Innovation

  • Defined market expansion and partnership strategy for medication adherence platform
  • Launched pilots with payers and providers; expanded monetization opportunities
Jan 2021 — Dec 2022
AdhereTech

AdhereTech

Vice President Innovation

  • Directed the strategic innovation initiatives that led to a 20% increase in patient adherence rates, significantly boosting overall health outcomes.
  • Managed cross-functional teams to integrate new features into AdhereTech's smart system, enhancing medication management for thousands of patients.
  • Spearheaded research and development on connecting patient care technologies, improving real-time intervention capabilities and therapeutic effectiveness.
Jan 2016 — Dec 2021
Omron Healthcare, Inc.

Omron Healthcare, Inc.

Exec. Director New Business Development, Corporate Development

  • Directed corporate development, B2B SaaS strategy, and strategic investments
  • Built B2B enterprise channel from $0 to $4M ARR in 3 years
  • Co-developed VitalSight chronic disease platform with EHR integration; executed clinical RPM pilots with Highmark Healthcare
  • Led $500M+ venture portfolio (Lark, AliveCor, CoHero)
Jan 2016 — Dec 2021
Omron Healthcare, Inc.

Omron Healthcare, Inc.

Director Corporate Strategy

Jan 2011 — Dec 2015
Samsung Next

Samsung Next

Principal

  • Established and led health tech venture capital investment program for $150m Fund
  • Led $475M+ investment portfolio: Glooko, BioBeats, CareInSync
Jan 2008 — Dec 2013

Personal Connected Health Alliance a division of HIMSS (formerly Continua Health Alliance)

Founding Board Director

Personal Connected Health Alliance, a division of HIMSS, focuses on advancing interoperability and improving connected health device standards.

  • Led the development of interoperability standards for over 185 member organizations, significantly improving the integration of connected health devices.
  • Played a key role in coordinating global partnerships that advanced the organization's mission of promoting personal health and wellness through connected technologies.
Jan 2006 — Dec 2011
Samsung Research America (SRA)

Samsung Research America (SRA)

Senior Manager of Business Development

  • Sourced technology and built strategic alliances across mobile health, diagnostics, and life sciences
  • Directed 2-year RPM clinical trial with Kaiser Permanente (240 patients)
  • Spearheaded go-to-market and compliance readiness for FDA-cleared diagnostic devices
Jan 2000 — Dec 2005

Cepheid

Senior Sales Specialist

  • Top national performer in diagnostic device sales; led strategic marketing and customer training
  • Salesperson of the Year 2004, 113% of plan
Jan 2000 — Dec 2005

Cepheid

Senior Sales

Jul 1996 — Nov 2000
Agilent Technologies

Agilent Technologies

Scientist

  • Hewlett Packard Labs – Agilent Technologies, Palo Alto, California
  • Developed IVD diagnostic tests and medical device hardware (2 patents issued), experimental design, execution and analysis
  • Trained technical support staff, and research associates, managed laboratory resources
Sep 1994 — Jul 1996

Clontech Laboratories, Inc.

Research Associate

  • Research and product development, experimental design, execution, and analysis, developed core products with PCR technology,
  • supported royalty negotiations, Provided technical service and customer support
  • PCR training by Dr. David Kellogg, lab associate for 1993 Nobel Prize winner (for the invention of PCR) Dr. Kary Mullis, at Cetus Labs